Close

Pacira Pharma (PCRX) Prelim. Q4, FY12 Revs Come in Ahead of Views

January 15, 2013 4:27 PM EST Send to a Friend
Pacira Pharma (Nasdaq: PCRX) is in the process of finalizing its results of operations and other financial and operating data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login